|
Characteristics
|
COR (95% CI)
|
P-value
|
AOR (95% CI)
|
P-value
|
|---|
|
Sex (n = 7826)
|
|
Male
|
0.917 (0.810, 1.038)
|
0.169
|
0.86 (0.74, 0.99)
|
0.047*
|
|
Female
|
1.00
| | | |
|
Age group (n = 7826)
|
|
15–24
|
1.00
| | | |
|
25–34
|
0.81 (0.67, 0.98)
|
0.029*
|
0.83 (0.61, 1.03)
|
0.092
|
|
35–44
|
0.82 (0.68, 1.00)
|
0.052
|
0.89 (0.71, 1.12)
|
0.304
|
|
45–54
|
0.82 (0.64, 0.1.04)
|
0.104
|
0.80 (0.61, 1.07)
|
0.134
|
|
> 55
|
0.97 (0.70, 1.36)
|
0.879
|
0.93 (0.63, 1.38)
|
0.719
|
|
Recent CD4 (n = 6187)
|
|
< 200
|
2.18 (1.81, 2.61)
|
0.001*
|
1.80 (1.45, 2.23)
|
0.001*
|
|
200-349
|
1.02 (0.85, 1.22)
|
0.851
|
0.99 (0.81, 1.21)
|
0.939
|
|
350–499
|
0.95 (0.79, 1.14)
|
0.556
|
0.94 (0.78, 1.14)
|
0.529
|
|
≥500
|
1.00
| | | |
|
Care status (n = 7826)
|
|
In pre-ART care
|
1.72 (1.36, .2.18)
|
0.001*
|
1.33 (0.95, 1.85)
|
0.093
|
|
In ART
|
1.00
| | | |
|
Taking any prophylactic medication for opportunistic infection
|
1.00
| | | |
|
Yes
|
0.84 (0.74, 0.96)
|
0.008
|
0.92 (0.77, 1.08)
|
0.296
|
|
No
|
|
Follow-up status (n = 7826)
|
1.00
| | | |
|
On active follow-up
|
1.11 (0.83, 1.50)
|
0.480
|
0.82 (0.56, 1.19)
|
0.292
|
|
Transferred-out
|
1.54 (1.22, 1.95)
|
0.001*
|
1.29 (0.93, 1.79)
|
0.125
|
|
Lost to follow-up
|
5.66 (3.71, 8.64)
|
0.001*
|
4.16 (2.26, 7.66)
|
0.001*
|
|
Died
|
|
Recent functional status (n = 7730)
|
|
Working
|
1.00
| | | |
|
Ambulatory or bed-ridden
|
4.75 (3.68, 6.13)
|
0.001
|
3.19 (2.32, 4.39)
|
0.001*
|
- *Significant at p-value < 0.05
